Related Experiment Video

Updated: Jun 10, 2026

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn
11:27

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn

Published on: April 7, 2023

Anticoagulation in neonates and children: Pitfalls and dilemmas

Paul Monagle1, Fiona Newall, Janine Campbell

  • 1Department of Clinical Haematology, Royal Children's Hospital, Parkville, Victoria 3052, Australia. paul.monagle@rch.org.au

Blood Reviews
|July 29, 2010
PubMed

Insights

Pediatric anticoagulation presents unique challenges compared to adults, necessitating specialized care. This review highlights common anticoagulants, knowledge gaps, and strategies for introducing new drugs in children.

Area of Science:

  • Pediatric Hematology
  • Pharmacology
  • Clinical Therapeutics

Background:

  • Anticoagulation therapy in children is complex due to patient-specific factors and drug properties.
  • Significant differences exist between pediatric and adult anticoagulation management.
  • Dedicated pediatric anticoagulation services are crucial for optimal patient outcomes.

Purpose of the Study:

  • To elucidate the complexities of pediatric anticoagulation.
  • To review current knowledge on common anticoagulants in children.
  • To discuss the introduction of novel anticoagulants in pediatric populations.

Main Methods:

  • Literature review and synthesis of existing data on pediatric anticoagulation.
  • Analysis of the properties and known effects of commonly used pediatric anticoagulants.
  • Discussion of evidence-based approaches for integrating new anticoagulant therapies.

Main Results:

  • Several factors make pediatric anticoagulation distinct from adult practice.
  • Specific knowledge gaps exist for widely used anticoagulants in children.
  • Evidence-based strategies are needed for the safe introduction of newer agents.

Conclusions:

  • Pediatric anticoagulation requires specialized services and careful consideration of unique patient needs.
  • Further research is essential to address existing knowledge deficits in pediatric anticoagulation.
  • Clinicians must judiciously apply available evidence for individualized patient management.

More Related Videos

Transcutaneous Microcirculatory Imaging in Preterm Neonates06:27

Transcutaneous Microcirculatory Imaging in Preterm Neonates

Published on: December 31, 2015

Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography09:31

Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography

Published on: January 27, 2023

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...